Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial

References

• Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJH, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J. 2007;29(1):56–63. doi:10.1183/09031936.00128505
   PubMed Web of Science ®Google Scholar
• Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nature Reviews Disease Primers. 2020;6(1):95. doi:10.1038/s41572-020-00227-0
   PubMed Web of Science ®Google Scholar
• Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764. doi:10.1183/09031936.04.00013904
   PubMed Web of Science ®Google Scholar
• Bousquet J, Fokkens W, Burney P, et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy. 2008;63(7):842–853. doi:10.1111/j.1398-9995.2008.01715.x
   PubMed Web of Science ®Google Scholar
• D’Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy. 2007;62(9):976–990. doi:10.1111/j.1398-9995.2007.01393.x
   PubMed Web of Science ®Google Scholar
• Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview. Clin Chem. 2003;49(1):32–40. doi:10.1373/49.1.32
   PubMed Web of Science ®Google Scholar
• Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352. doi:10.1002/alr.22073
   PubMed Web of Science ®Google Scholar
• Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin. 2004;20(3):305–317. doi:10.1185/030079903125003053
   PubMed Web of Science ®Google Scholar
• Wise SK, Damask C, Roland LT, et al. International consensus statement on allergy and rhinology: allergic rhinitis - 2023. Int Forum Allergy Rhinol. 2023;13(4):293–859. doi:10.1002/alr.23090
   PubMed Web of Science ®Google Scholar
• Simons FER, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1(9):145–155. doi:10.1186/1939-4551-1-9-145
   PubMedGoogle Scholar
• Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol. 2001;108(1 Suppl):S59–64. doi:10.1067/mai.2001.115568
   PubMed Web of Science ®Google Scholar
• Andersson M, Greiff L, Ojeda P, Wollmer P. Barrier-enforcing measures as treatment principle in allergic rhinitis: a systematic review. Curr Med Res Opin. 2014;30(6):1131–1137. doi:10.1185/03007995.2014.882299
   PubMed Web of Science ®Google Scholar
• Pacheco-Quito E-M, Ruiz-Caro R, Veiga M-D. Carrageenan: drug delivery systems and other biomedical applications. Mar Drugs. 2020;18(11):583. doi:10.3390/md18110583
   PubMed Web of Science ®Google Scholar
• Schütz D, Conzelmann C, Fois G, et al. Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol. 2021;320:L750–L756. doi:10.1152/ajplung.00552.2020
   PubMed Web of Science ®Google Scholar
• Große M, Ruetalo N, Businger R, et al. Evidence that quinine exhibits antiviral activity against SARS-CoV-2 infection in vitro; 2020.
   Google Scholar
• Hebar A, Koller C, Seifert J-M, et al. Non-clinical safety evaluation of intranasal iota-carrageenan. PLoS One. 2015;10(4):e0122911. doi:10.1371/journal.pone.0122911
   PubMed Web of Science ®Google Scholar
• Mono chem-pharm Produkte GmbH. VisAlpin Instruction for Use. Available from: https://visalpin.at/wp-content/uploads/2018/03/Gebrauchsanweisung_Schnupfenspray_D-EN_12102020.pdf. Accessed October 3, 2023.
   Google Scholar
• Day JH, Briscoe MP, Rafeiro E, Ellis AK, Pettersson E, Akerlund A. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol. 2000;105(3):489–494. doi:10.1067/mai.2000.104550
   PubMed Web of Science ®Google Scholar
• Devillier P, Le Gall M, Horak F. The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy. Allergy. 2011;66(2):163–169. doi:10.1111/j.1398-9995.2010.02473.x
   PubMed Web of Science ®Google Scholar
• Gross GN, Berman G, Amar NJ, Caracta CF, Tantry SK. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2019;122(6):630–638.e3. doi:10.1016/j.anai.2019.03.017
   PubMed Web of Science ®Google Scholar
• Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mösges R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2012;26(5):e119–25. doi:10.2500/ajra.2012.26.3787
   PubMed Web of Science ®Google Scholar
• Nasaleze International Ltd. Clinical research on Nasaleze; 2023. Available from: https://nasaleze.mk/wp-content/uploads/2020/10/Allergyl-Clinical-Trials-ENG.pdf. Accessed January 16, 2024.
   Google Scholar
• Nehrig J, Grosse N, Hohenfeld IP, Hohlfeld JM, Badorrek P. Efficacy and safety of a drug-free, barrier-forming nasal spray for allergic rhinitis: randomized, open-label, crossover noninferiority trial. Int Arch Allergy Immunol. 2023;184(2):111–121. doi:10.1159/000526423
   PubMed Web of Science ®Google Scholar
• Stoelzel K, Bothe G, Chong PW, Lenarz M. Safety and efficacy of Nasya/Prevalin in reducing symptoms of allergic rhinitis. Clin Respirat J. 2014;8(4):382–390. doi:10.1111/crj.12080
   PubMed Web of Science ®Google Scholar
• Schwetz S, Olze H, Melchisedech S, Grigorov A, Latza R. Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2004;130(8):979–984. doi:10.1001/archotol.130.8.979
   PubMedGoogle Scholar
• Geisthoff UW, Blum A, Rupp-Classen M, Plinkert P-K. Lipid-based Nose Ointment for Allergic Rhinitis. Otolaryngol Head Neck Surg. 2005;133(5):754–761. doi:10.1016/j.otohns.2005.06.026
   PubMed Web of Science ®Google Scholar
• Aberg N, Dahl A, Benson M. A nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in children and adolescents; reduction of symptoms and relation to pollen load. Pediatr Allergy Immunol. 2011;22(6):594–599. doi:10.1111/j.1399-3038.2011.01182.x
   PubMed Web of Science ®Google Scholar
• Emberlin JC, Lewis RA. A double blind, placebo-controlled cross over trial of cellulose powder by nasal provocation with Der p1 and Der f1. Curr Med Res Opin. 2007;23(10):2423–2431. doi:10.1185/030079907X231144
   PubMed Web of Science ®Google Scholar
• Graf C, Bernkop-Schnürch A, Egyed A, Koller C, Prieschl-Grassauer E, Morokutti-Kurz M. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis. Int J Gen Med. 2018;11:275–283. doi:10.2147/IJGM.S167123
   PubMed Web of Science ®Google Scholar
• Fazekas T, Eickhoff P, Pruckner N, et al. Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med. 2012;12:147. doi:10.1186/1472-6882-12-147
   PubMed Web of Science ®Google Scholar